RecruitingNCT02602769

Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

Studying Rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Columbia University
Principal Investigator: Vidhu Thaker, MD
Columbia University
Intervention: Transcriptome profiling(diagnostic_test)
Enrollment: 12 target
Eligibility: 2-20 years · All sexes
Timeline: 2015 – 2026

Study locations (2)

Boston Children's Hospital, Boston, New York, United States
Columbia University Irving Medical Center, New York, New York, United States

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · ROHHAD Association

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02602769 on ClinicalTrials.gov

Other trials for Rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGNCT03135730
International Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation & Autonomic Dysregulation (ROHHAD) Registry
Debra Weese-Mayer

See all trials for Rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome →

← Back to all trials